{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:57:32Z","timestamp":1787021852269,"version":"build-2736575974"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,30]],"date-time":"2011-08-30T00:00:00Z","timestamp":1314662400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024211","type":"journal-article","created":{"date-parts":[[2011,8,30]],"date-time":"2011-08-30T16:53:37Z","timestamp":1314723217000},"page":"e24211","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["An Exploratory Study on CLU, CR1 and PICALM and Parkinson Disease"],"prefix":"10.1371","volume":"6","author":[{"given":"Jianjun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YikYung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Hollenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease.","volume":"10","author":"CA Ross","year":"2004","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S358","DOI":"10.1002\/mds.21677","article-title":"Cognitive dysfunction and dementia in Parkinson disease.","volume":"22","author":"N Caballol","year":"2007","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.54.6.1284","article-title":"Progression of parkinsonian signs in Alzheimer's disease.","volume":"54","author":"RS Wilson","year":"2000","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archneur.61.7.1033","article-title":"Lack of familial aggregation of Parkinson disease and Alzheimer disease.","volume":"61","author":"G Levy","year":"2004","journal-title":"Arch Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.39.12.1589","article-title":"History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease.","volume":"39","author":"A Hofman","year":"1989","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1468-1331.2010.02974.x","article-title":"Familial associations of Alzheimer disease and essential tremor with Parkinson disease.","volume":"17","author":"S Costello","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10048-007-0100-6","article-title":"Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.","volume":"8","author":"AR Rosen","year":"2007","journal-title":"Neurogenetics"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.52.4.719","article-title":"Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia.","volume":"52","author":"K Marder","year":"1999","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.","volume":"41","author":"D Harold","year":"2009","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.","volume":"41","author":"JC Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","article-title":"Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.","volume":"67","author":"G Jun","year":"2010","journal-title":"Arch Neurol"},{"key":"ref12","first-page":"595","article-title":"The clinical features of Parkinson's disease in 100 histologically proven cases.","volume":"60","author":"AJ Hughes","year":"1993","journal-title":"Adv Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1212\/01.WNL.0000130159.28215.6A","article-title":"APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease.","volume":"62","author":"X Huang","year":"2004","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.","volume":"256","author":"CH Williams-Gray","year":"2009","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2006.07.037","article-title":"Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.","volume":"406","author":"L Blazquez","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.jnen.0000199572.96472.1c","article-title":"Relationship of apolipoprotein E and age at onset to Parkinson disease neuropathology.","volume":"65","author":"E Ghebremedhin","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.63.3.394","article-title":"Apolipoprotein E genotype in familial Parkinson's disease. The French Parkinson's Disease Genetics Study Group.","volume":"63","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.12.008","article-title":"Phenotypic associations of tau and ApoE in Parkinson's disease.","volume":"414","author":"S Papapetropoulos","year":"2007","journal-title":"Neurosci Lett"},{"key":"ref19","article-title":"Apolipoprotein E genotypes and the risk of Parkinson disease.","author":"JJ Gao","journal-title":"Neurobiol Aging"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.22013","article-title":"Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study.","volume":"23","author":"X Huang","year":"2008","journal-title":"Mov Disord"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/aje\/kwj283","article-title":"Serum cholesterol levels and the risk of Parkinson's disease.","volume":"164","author":"LM de Lau","year":"2006","journal-title":"Am J Epidemiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.wnl.0000271883.45010.8a","article-title":"Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.","volume":"69","author":"KC Simon","year":"2007","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","article-title":"Clusterin: a forgotten player in Alzheimer's disease.","volume":"61","author":"T Nuutinen","year":"2009","journal-title":"Brain Res Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tig.2009.12.004","article-title":"The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects.","volume":"26","author":"K Sleegers","year":"2010","journal-title":"Trends Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-002-0546-4","article-title":"Clusterin\/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.","volume":"104","author":"K Sasaki","year":"2002","journal-title":"Acta Neuropathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jnr.20374","article-title":"Upregulation of clusterin\/apolipoprotein J in lactacystin-treated SH-SY5Y cells.","volume":"79","author":"I Carreras","year":"2005","journal-title":"J Neurosci Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00702-010-0462-z","article-title":"CSF markers of neurodegeneration in Parkinson's disease.","volume":"117","author":"H Prikrylova Vranova","year":"2010","journal-title":"J Neural Transm"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.","volume":"57","author":"AJ Hughes","year":"2001","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/aje\/154.12.1119","article-title":"Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.","volume":"154","author":"A Schatzkin","year":"2001","journal-title":"Am J Epidemiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.0b013e3181d55f38","article-title":"Smoking duration, intensity, and risk of Parkinson disease.","volume":"74","author":"H Chen","year":"2010","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.","volume":"50","author":"A Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.","volume":"58","author":"H Chen","year":"2005","journal-title":"Ann Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ana.10381","article-title":"Diet and Parkinson's disease: a potential role of dairy products in men.","volume":"52","author":"H Chen","year":"2002","journal-title":"Ann Neurol"},{"key":"ref34","author":"W Gauderman","year":"2006"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T17:46:18Z","timestamp":1592847978000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024211"}},"subtitle":[],"editor":[{"given":"Yiqing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,30]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024211","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,30]]}}}